According to the Market Statsville Group (MSG), the Global Custom Oligonucleotide Synthesis and Gene Synthesis Market size is expected to project a considerable CAGR of 10.6% from 2024 to 2033.
The genetic research field and biotechnology progression toward personalized medicine continue to drive the future of the custom oligonucleotide synthesis and gene synthesis markets. As these are short DNA or RNA molecules, oligonucleotides become essential diagnostic and therapeutic tools and research reagents. Synthetic genes in gene therapies, synthetic biology, and vaccine development surge in demand and become the driver of the main market. Lower costs and increases in these services' availability have steadily become possible because of technological advancements in high-throughput synthesis and automation.
In addition, the oligonucleotides find various applications in gene editing technologies such as the famous CRISPR, thus increasing demand. North America has a large market share due to the developed local research infrastructure and the presence of a robust biotech industry, while Asia-Pacific is a land of potential opportunities due to the increasing investments being made in the country toward biotech research and development. Overall, the market itself is going to progress while innovations continue, and the applications keep on increasing within life sciences.
Custom oligonucleotide synthesis is the laboratory procedure for creating short sequences of nucleotides (DNA or RNA) that can be tailored to the desired specifications; it has applications in research, diagnostics, and therapeutics. In contrast, gene synthesis is the artificial construction of entire genes to study their function or apply it in synthetic biology, gene therapy, and biotechnology, thus promoting genetic research and personalized medicine.
Advancements in biotechnology are fueling the research process in the custom oligonucleotide and gene synthesis market. Improvements to genetic studies, such as NGS and paired-end sequencing, and the latest in gene editing with the CRISPR-Cas9 technique, are fundamentally transforming the concept of genetics and new possibilities for treating and preventing diseases. Synthetic biology—the process of composing and constructing new parts, devices, and biological systems—employs synthesized genes and oligonucleotides as the foundation upon which the construction of new organisms and biological functions relies.
Custom oligonucleotides for individualized treatment in medicine, whose therapy concept is determined by the characteristics of each patient, find application in precise diagnostics and target-oriented therapies, as, for instance, antisense oligonucleotides and techniques involving RNA interference. Developments along these lines need access to top-quality, specially designed genetic material and hence drive demand for oligonucleotide and gene synthesis services. Such rapid synthesis and modification of genes have been major driving forces in exploring innovative solutions in many areas to help patients.
The high cost prevails in custom oligonucleotide and gene synthesis, particularly for the synthesis of long or complex sequences. Apart from the financial relief offered by technological advancement, the synthesis of these involves sophisticated workup machinery and high-grade reagents, coupled with stringent measures of quality control—all adding to the expense.
Moreover, customization for a given research or therapeutic purpose adds again to the cost. These expenses can hence be prohibitive for smaller research institutions or startups, therefore basically limiting access to needed synthetic genetic materials. Also, huge financial investments go into scaling up production for commercial applications or large-scale studies. In that respect, while demand for custom synthesis services is growing, high costs are likely to be a barrier to broader adoption and innovation, especially in resource-limited settings.
The study categorizes the Custom Oligonucleotide Synthesis and Gene Synthesis market based on product type, technology and end-users at the regional and global levels.
Based on the product type, the market is divided into Custom Oligonucleotides, Custom Genes, DNA Libraries, and Others. Custom oligonucleotides dominate the segment of the custom oligonucleotide and gene synthesis market due to the extensive range of applications in research, diagnostics, and therapeutics. This makes them one of the tools of great importance for PCR, qPCR, sequencing, and gene editing, and therefore very crucial for molecular biology and genetic studies. The upsurge of CRISPR technology, among other gene editing techniques, caused intensive demand for very specific and valid oligonucleotides.
Furthermore, they fine-tune personalized medicines and include targeted therapies and diagnostic assays. The applications run by custom oligonucleotide chains are relatively cost-effective compared to those run by whole gene synthesis. Another reason for wide application and market leadership is their versatility. Finally, the continued upgrade of synthesis technology, which improves the efficiency and accuracy of custom oligonucleotides, cements the market-leading position.
Based on the regions, the global market of Custom Oligonucleotide Synthesis and Gene Synthesis has been segmented across North America, Europe, the Middle East & Africa, South America, and Asia-Pacific. North America dominates the largest market share of custom oligonucleotide and gene synthesis because it holds one of the most advanced research infrastructures across the globe, having among the most developed biotech sectors with huge investments in genetic research. There are a great number of leading biotech companies, research institutions, and universities generating innovation and demand for custom synthesis services situated in this region. Besides, established healthcare systems and favorable environments for regulations boost market growth.
In addition, high funding both by government authorities and private investors into research and development within the genetics, personalized medicine, and synthetic biology areas bootstraps these applications. This North American leadership is also supported by the early adoption of more advanced technologies, as realized with the CRISPR and next-generation sequencing market too. Coupling this with a view that the region has strong strides in precision medicine and oligonucleotides' growing application in diagnostics and therapeutics, demand for custom synthesis will be robust.
The global custom oligonucleotide and gene synthesis market is very competitive, with key players in the investment portfolio including Thermo Fisher Scientific, Integrated DNA Technologies, and Eurofins Genomics. The competition among all entities is at the level of technological advancement, quality, and what each provides to their respective clients; for that matter, mergers, acquisitions, and partnerships are common moves to enhance one's market presence and extend capabilities in response to growing demand.
Frequently Asked Questions
Want to Review Complete Market Research Report
Budget constraints? Get in touch with us for special pricing
Request for Special PricingCustomize this Report
Related Reports
Biocides for Leather Market 2022: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2030
Mar 2024Rubber Gloves Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2027
Mar 2024Plastics Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2027
Mar 2024Polyamide Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Opportunities, and Forecast By 2027
Mar 2024Anhydrous Sulphuric Acid Market 2021: Industry Size, Regions, Emerging Trends, Growth Insights, Development Scenario, Opportunities, and Forecast By 2027
Mar 2024